What is Etanercept?
Category: Prescription Drugs
Most popular types: Enbrel Enbrel SureClick Enbrel Prefilled Syringe Show all
Etanercept is an antirheumatic drug that helps block inflammation. It may be used to treat certain auto-immune conditions including rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Rheumatoid arthritis | 3796 | 196 | |
| Psoriatic arthritis | 485 | 94 | |
| Psoriasis | 465 | 39 | |
| Ankylosing spondylitis | 274 | 26 | |
| Polyarticular onset juvenile arthritis | 29 | 8 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 38 | |
| Moderate | 48 | |
| Mild | 96 | |
| None | 167 |
Commonly reported side effects and conditions associated with Etanercept
| Side effect | Patients | Percentage |
|---|---|---|
| Fatigue | 17 | |
| Headaches | 9 | |
| Bruising | 8 | |
| Injection site itching | 7 | |
| Injection site pain | 7 | |
| Injection site redness | 7 |
Why patients stopped taking Etanercept
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Did not seem to work | 159 | |
| Doctor's advice | 81 | |
| Side effects too severe | 63 | |
| Other | 46 | |
| Expense | 22 | |
| Change in health plan coverage | 10 | |
| Course of treatment ended | 9 | |
| Personal research | 3 |
Duration
Stopped taking Etanercept
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 35 | |
| 1 - 6 months | 61 | |
| 6 months - 1 year | 60 | |
| 1 - 2 years | 50 | |
| 2 - 5 years | 40 | |
| 5 - 10 years | 21 | |
| 10 years or more | 14 |
What people switch to and from
Patients started taking Etanercept after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Methotrexate (Apo-Methotrexate) | 42 | |
| Adalimumab (Humira) | 41 | |
| Hydroxychloroquine (Plaquenil) | 12 | |
| Leflunomide (Arava) | 11 | |
| Infliximab (Remicade) | 5 |
Patients stopped taking Etanercept and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Adalimumab (Humira) | 58 | |
| Golimumab (Simponi) | 11 | |
| Infliximab (Remicade) | 10 | |
| Abatacept (Orencia) | 8 | |
| Certolizumab (Cimzia) | 8 |
Last updated: